| Safe Use of Opioids
|
SESLHDGL/105 |
|
| Perioperative Suite - Ensuring that only duly authorised persons are able to enter SESLHD Perioperative Suites
|
SESLHDPR/207 |
|
| Pain Management - Opioid Withdrawal in Patients on Long Term Opioid Medications
|
SESLHDPR/603 |
|
| Outside Practice and Other Business Activities - Process
|
SESLHDPR/563 |
|
Outbreak Management and Contact Tracing
|
SESLHDPR/685 |
|
| Orientation and Induction- New Employees
|
SESLHDPD/172 |
|
| Organ Tissue Donation following Neurological Determination of Death
|
SESLHDPR/231 |
|
Ordering of supplies for staff tearooms
Ordering of supplies for staff tearooms order form
|
SESLHDPD/321 |
|
| Open Disclosure
|
SESLHDGL/058 |
|
| Online Communications policy
|
SESLHDPD/243 |
|
| Ocrelizumab for Multiple Sclerosis
|
SESLHDPR/629 |
|
| Occupational Therapy (OT) Home Visits for inpatients requiring assessment by an Aged Care Assessment Team (ACAT)
|
SESLHDGL/090 |
|
| Observation of the neonate following instrumental delivery
|
SESLHDPR/414 |
|
| Medication Charts: Charting of Oral Nutrition Support
|
SESLHDPR/317 |
|
| Management of Organisational Restructures and Other Reforms in SESLHD
|
SESLHDPR/744 |
|
| Management of missed consecutive doses of Opioid Agonist Treatment in Inpatient and Outpatient settings
|
SESLHDPR/411 |
|
| Biometry and Ocular Ultrasonography
|
SESLHDPR/749 |
|
| Assessment of Ethambutol Optic Neuropathy
|
SESLHDGL/107 |
|
| Advanced Recovery Orthopaedic Program (AROP) Anaesthetic Guideline
|
SESLHDGL/059 |
|
